Top

Reactions Weekly

Published in:

01-10-2023 | Psoriatic Arthritis | Case report

Guselkumab

Treatment failure: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Ruiz DEL Valle V, et al. GUSELKUMAB EFFICACY AND SAFETY ANALYSIS FOR PSA ACCORDING TO BASELINE CHARACTERISTICS AS GENDER, OBESITY OR PREVIOUS TREATMENT IN REAL LIFE AFTER 52 WEEKS. Annals of the Rheumatic Diseases 82 (Suppl. 1): 1789-1790 abstr. AB1119, Jun 2023. Available from: URL: http://doi.org/10.1136/annrheumdis-2023-eular.2055 [abstract]

Title: Guselkumab
Treatment failure: case report
Publication date: 01-10-2023
Publisher: Springer International Publishing
Keywords: Psoriatic Arthritis
Guselkumab
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-47938-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Guselkumab

Treatment failure: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Daptomycin

Valproic-acid

Lamotrigine/valproic-acid

Dopamine/norepinephrine/vasopressin

Gemcitabine/paclitaxel

Isoniazid